Evidence map›Paper›PMID 34202378›Full record

ArticleMolecules (Basel, Switzerland)2021

The Modulation of PCSK9 and LDLR by Supercritical CO

Stefania Sut, Irene Ferrarese, Maria Giovanna Lupo, Nicola De Zordi, Elisa Tripicchio, Nicola Ferri, Stefano Dall' Acqua

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stefania SutDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy.
Irene FerrareseDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy.
Maria Giovanna LupoDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy.ORCID 0000-0002-4236-4414
Nicola De ZordiSocietà Agricola Moldoi - S.A.M, SrL, Loc. Maras Moldoi 151/a, 32037 Sospirolo, Italy.ORCID 0000-0002-6524-3041
Elisa TripicchioSocietà Agricola Moldoi - S.A.M, SrL, Loc. Maras Moldoi 151/a, 32037 Sospirolo, Italy.
Nicola FerriDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy.ORCID 0000-0001-8898-7441
Stefano Dall' AcquaDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy.ORCID 0000-0001-8264-6953
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study the ability of supercritical carbon dioxide (SCO

Indexed as

Cyclohexane MonoterpenesCarbon DioxideHep G2 CellsHumansMenthaPlant ExtractsProprotein Convertase 9Receptors, LDLCarbon DioxideCyclohexane MonoterpenesLDLR protein, humanPCSK9 protein, humanPlant ExtractsProprotein Convertase 9Receptors, LDLfatty acidsLDLRMenta longifolianutraceuticalPCSK9phytosterolspiperitone oxideterpenoids

Identifiers

PMID34202378
PMCPMC8272093
OpenAlexW3176595004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.